Reed Sinopharm Exhibitions announced the launch of the Health Industry Summit (tHIS) in Shanghai to be held May 15-18, 2015, at the National Exhibition and Conference Center.
A joint venture between Reed Exhibitions, the world’s leading events organizer, and Sinopharm, China’s largest, state-owned pharmaceutical group, will combine a summit program of more than 100 conferences with a 260,000-square-meter exhibition area.
Co-locating three of the leading health industry exhibitions – CMEF, PHARMCHINA and API CHINA – tHIS will effectively form the world’s largest integrated health industry event.
Such a grand international event is intended to secure more trade and influence for China’s already sizable sector. Predicting a health industry growth of $1.2 trillion by 2020, it comes as no surprise Reed Sinopharm would decide to host the summit.
Along with the exhibition which completes the value chain for pharmaceutical and medical industries, an extensive conference program is designed to share the latest thinking on policies and investment, R&D, manufacturing and distribution, professional education and hospital applications.
It is estimated that more than 6,000 exhibitors and a staggering 150,000 professional visitors and leading academics from 140 countries and regions will land in Shanghai next May to join this unique event, bringing in significant business service and tourism revenue opportunities to the city.
Apart from scale, tHIS has also positioned itself as the platform to explore synergies emerging from the interactions between and within the pharmaceutical and medical sectors, which share a significant base of distributors and end users, as more companies begin to operate in a cross-sector capacity.
As China’s health care sector only accounts for around 5 percent of China’s GDP, there remains abundant potential for further investments and growth, especially when it is fueled by favorable demographic trends and continuing urbanization.